Compile Data Set for Download or QSAR
Found 291 with Last Name = 'maung' and Initial = 'j'
TargetEpidermal growth factor receptor(Human)
NewGen Therapeutics, Inc.

US Patent
LigandPNGBDBM192317(US9187459, 2)copy SMILEScopy InChI
Affinity DataIC50: 0.130nMT: 2°CAssay Description:1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dil...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q25719TFUS Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538576(CHEMBL4634092)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538560(CHEMBL4640002)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538572(CHEMBL4649132)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538575(CHEMBL4638458)copy SMILEScopy InChI
Affinity DataIC50: 0.320nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetEpidermal growth factor receptor(Human)
NewGen Therapeutics, Inc.

US Patent
LigandPNGBDBM192320(US9187459, 5)copy SMILEScopy InChI
Affinity DataIC50: 0.370nMT: 2°CAssay Description:1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dil...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q25719TFUS Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538562(CHEMBL4643330)copy SMILEScopy InChI
Affinity DataIC50: 0.380nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538578(CHEMBL4640729)copy SMILEScopy InChI
Affinity DataIC50: 0.390nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetEpidermal growth factor receptor(Human)
NewGen Therapeutics, Inc.

US Patent
LigandPNGBDBM192316(US9187459, 1)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMT: 2°CAssay Description:1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dil...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q25719TFUS Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538579(CHEMBL4647217)copy SMILEScopy InChI
Affinity DataIC50: 0.440nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetEpidermal growth factor receptor(Human)
NewGen Therapeutics, Inc.

US Patent
LigandPNGBDBM192319(US9187459, 4)copy SMILEScopy InChI
Affinity DataIC50: 0.510nMT: 2°CAssay Description:1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dil...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q25719TFUS Patent
TargetEpidermal growth factor receptor(Human)
NewGen Therapeutics, Inc.

US Patent
LigandPNGBDBM192318(US9187459, 3)copy SMILEScopy InChI
Affinity DataIC50: 0.540nMT: 2°CAssay Description:1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dil...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q25719TFUS Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538582(CHEMBL4638998)copy SMILEScopy InChI
Affinity DataIC50: 0.780nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetGlutamate carboxypeptidase 2(Human)
San Francisco State University

Curated by ChEMBL
LigandPNGBDBM50222546(CHEMBL241779 | tetralithium (2S)-2-(phosphonatoami...)copy SMILEScopy InChI
Affinity DataIC50: 0.860nMAssay Description:Inhibition of PSMAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2057FMFPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538570(CHEMBL4638573)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538563(CHEMBL4648116)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538564(CHEMBL4641569)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538583(CHEMBL4643112)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538577(CHEMBL4648623)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538567(CHEMBL4633860)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591075(CHEMBL5200118)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538569(CHEMBL4644317)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetGlutamate carboxypeptidase 2(Human)
San Francisco State University

Curated by ChEMBL
LigandPNGBDBM50222549((S)-2-phosphonoamino-pentanedioic acid | CHEMBL238...)copy SMILEScopy InChI
Affinity DataIC50: 2.30nMAssay Description:Inhibition of PSMAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2057FMFPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538581(CHEMBL4642862)copy SMILEScopy InChI
Affinity DataIC50: 2.40nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591046(CHEMBL5202342)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538568(CHEMBL4640563)copy SMILEScopy InChI
Affinity DataIC50: 3.40nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538565(CHEMBL4635798)copy SMILEScopy InChI
Affinity DataIC50: 4.60nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591045(CHEMBL5209076)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591054(CHEMBL5179922)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591066(CHEMBL5190023)copy SMILES
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
NewGen Therapeutics, Inc.

US Patent
LigandPNGBDBM192317(US9187459, 2)copy SMILEScopy InChI
Affinity DataIC50: 6nMT: 2°CAssay Description:1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dil...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q25719TFUS Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538574(CHEMBL4638688)copy SMILEScopy InChI
Affinity DataIC50: 6.60nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538566(CHEMBL4632475)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591079(CHEMBL5196751)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591070(CHEMBL5208600)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591075(CHEMBL5200118)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538556(CHEMBL4646914)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591081(CHEMBL5193210)copy SMILES
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591044(CHEMBL5202445)copy SMILES
Affinity DataIC50: 11nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538561(CHEMBL4642308)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591077(CHEMBL5201930)copy SMILES
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetGlutamate carboxypeptidase 2(Human)
San Francisco State University

Curated by ChEMBL
LigandPNGBDBM50222551(CHEMBL241780 | tetralithium (2S)-2-(phosphonatooxy...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:Inhibition of PSMAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2057FMFPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591065(CHEMBL5170361)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591066(CHEMBL5190023)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591065(CHEMBL5170361)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591072(CHEMBL5172690)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591064(CHEMBL5199369)copy SMILES
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591054(CHEMBL5179922)copy SMILES
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591064(CHEMBL5199369)copy SMILES
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
Displayed 1 to 50 (of 291 total ) | Next | Last >>
Jump to: